---

---

sector : Communications    symbols : Snynf   

save search

---

PRODUCT OF THE YEAR USA NAMES 2024 AWARD WINNERS
Published: 2024-02-09 (Crawled : 14:00) - prnewswire.com
K | $56.18 0.2% 310K |

Consumer Non-Durables

| 2.06% | O: -0.38% H: 0.03% C: -2.27%
EPC 4 | $35.9 1.64% 37K |

Consumer Non-Durables

| -10.16% | O: -0.35% H: 0.61% C: 0.31%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| 0.04% | O: 1.11% H: 0.0% C: 0.0%
award year usa

---

Publicis Groupe : Full Year 2023 Results
Published: 2024-02-08 (Crawled : 07:00) - globenewswire.com
FNCTF | News | $11.0354 34K |

Communications

| -5.11% | O: -2.28% H: 0.0% C: 0.0%
SNYNF | News | $92.7 1.4K |

Health Technology

| -1.05% | O: -1.64% H: 0.0% C: 0.0%
K | $56.18 0.2% 310K |

Consumer Non-Durables

| 4.43% | O: 3.37% H: 1.93% C: -1.01%
KBH S | $61.65 1.2% 360K |

Consumer Durables

| 1.58% | O: 0.25% H: 1.03% C: 0.9%
GM | News | $42.625 0.39% 3.1M |

Consumer Durables

| 9.66% | O: 0.31% H: 0.26% C: -0.49%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -2.21% | O: -2.25% H: 0.0% C: 0.0%
year results

---

Sanofi Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
Published: 2024-01-11 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -10.95% | O: 1.1% H: 0.0% C: 0.0%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -11.29% | O: 0.69% H: 0.0% C: 0.0%
report innovation sanofi

---

Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | $140.15 560 |

Health Technology

| 2.12% | O: -3.0% H: 2.15% C: 2.15%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -4.45% | O: 0.0% H: 0.0% C: 0.0%
NVO | News | $123.37 -0.93% 1.4M |

Health Technology

| 27.07% | O: -0.48% H: 0.0% C: -0.44%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -5.86% | O: -1.31% H: 0.56% C: -0.17%
LLY | News | $749.245 -0.2% 550K |

Health Technology

| 26.46% | O: -4.44% H: 0.0% C: 0.0%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -4.53% | O: -0.93% H: 0.0% C: 0.0%
AZN | $68.635 0.15% 1.3M |

Health Technology

| 2.89% | O: -2.23% H: 0.28% C: -0.11%
reach research market

---

Sodexo announces the composition of Pluxee’s future Board of Directors
Published: 2023-12-13 (Crawled : 07:00) - globenewswire.com
LDNXF | $112.5665 1.3K |

Finance

| -1.8% | O: 2.99% H: 0.0% C: -2.02%
SNYNF | News | $92.7 1.4K |

Health Technology

| -1.13% | O: -0.06% H: 2.36% C: 2.36%
BGAOY | News | $1.5 1.1K |

Information

| -18.01% | O: 1.56% H: 0.0% C: 0.0%
LNSTY | $28.6457 130K |

Finance and Insurance

| -2.13% | O: -0.61% H: 2.21% C: 1.81%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -2.74% | O: -0.27% H: 2.28% C: 2.16%

---

Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 1.4K |

Health Technology

| -0.41% | O: -0.35% H: 0.0% C: 0.0%
TEVA | $13.09 -0.68% 990K |

Health Technology

| 36.02% | O: -0.52% H: 3.73% C: 1.87%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -1.05% | O: -1.09% H: 0.0% C: 0.0%
disease treatment collaboration teva deal

---

Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published: 2023-11-25 (Crawled : 08:20) - prnewswire.com
SNY | News | $45.56 -1.19% 910K |

Health Technology

| Email alert Add to watchlist
ELAN | $13.55 1.04% 1.1M |

Process Industries

| Email alert Add to watchlist
SNYNF | News | $92.7 1.4K |

Health Technology

| Email alert Add to watchlist
NVS | News | $92.61 -0.51% 430K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
ZTS | News | $152.565 0.69% 1.2M |

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 34K |

Communications

| Email alert Add to watchlist
vaccine reach research market

---

Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 1.4K |

Health Technology

| 1.88% | O: -0.33% H: 0.0% C: 0.0%
TEVA | $13.09 -0.68% 990K |

Health Technology

| 45.8% | O: 2.54% H: 3.23% C: -1.29%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| 2.31% | O: 1.62% H: 0.0% C: 0.0%
revenue teva financial results

---

Oral Antibiotics Market to Reach $28.8 Billion, Globally, by 2032 at 2.5% CAGR: Allied Market Research
Published: 2023-10-25 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -10.43% | O: 0.4% H: 1.29% C: 1.29%
VTRS | $11.22 1.08% 510K |

Health Technology

| 21.84% | O: -0.44% H: 0.33% C: -1.1%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -1.93% | O: 0.64% H: 0.46% C: -0.09%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -11.99% | O: 1.43% H: 0.64% C: -0.09%
reach antibiotics research market

---

Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
VTRS | $11.22 1.08% 510K |

Health Technology

| 24.44% | O: 0.45% H: 2.46% C: 1.67%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -1.7% | O: -0.17% H: 1.02% C: 0.4%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -11.31% | O: 0.77% H: 0.0% C: 0.0%
reach research market

---

Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published: 2023-06-30 (Crawled : 18:00) - prnewswire.com
SRNE | $0.028 42K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 1.4K |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.56 -1.19% 910K |

Health Technology

| Email alert Add to watchlist
IMGN | $31.23 0.03% 49M |

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 34K |

Communications

| Email alert Add to watchlist
drug companies antibody

---

Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-26 (Crawled : 21:00) - prnewswire.com
LLY | News | $749.245 -0.2% 550K |

Health Technology

| 65.82% | O: 2.15% H: 1.18% C: 0.43%
SRNE | $0.028 42K |

Health Technology

| -91.4% | O: -1.0% H: 4.2% C: 1.3%
SGEN | $228.74 0.1% 20M |

Health Technology

| 16.38% | O: 0.82% H: 0.02% C: -0.85%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -13.78% | O: 0.17% H: 0.0% C: 0.0%
OMER | $3.395 1.65% 120K |

Health Technology

| -38.15% | O: 0.19% H: 2.22% C: 1.76%
IMGN | $31.23 0.03% 49M |

Health Technology

| 65.12% | O: 0.58% H: 2.57% C: 0.26%
companies pipeline trial

---

Extended Release Injectable Drugs Research Report 2023: Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape
Published: 2023-06-16 (Crawled : 23:00) - prnewswire.com
FNCTF | News | $11.0354 34K |

Communications

| Email alert Add to watchlist
SNY | News | $45.56 -1.19% 910K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 1.4K |

Health Technology

| Email alert Add to watchlist
report control research

---

IPG Named Most Effective Holding Company at the U.S. Effie Awards
Published: 2023-06-02 (Crawled : 22:00) - interpublic.com
SNY | News | $45.56 -1.19% 910K |

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 34K |

Communications

| Email alert Add to watchlist
SNYNF | News | $92.7 1.4K |

Health Technology

| Email alert Add to watchlist
awards

---

IPG Receives Back-to-Back Title as Most Effective Holding Company at the Effie Awards
Published: 2023-06-02 (Crawled : 20:00) - interpublic.com
SNY | News | $45.56 -1.19% 910K |

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 34K |

Communications

| Email alert Add to watchlist
SNYNF | News | $92.7 1.4K |

Health Technology

| Email alert Add to watchlist
awards

---

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -5.89% | O: -0.27% H: 0.1% C: 0.1%
NTRB | $4.27 4.8K |

Manufacturing

| 21.65% | O: -2.85% H: 0.0% C: -1.76%
RANI | $6.69 -14.78% 340K |

| 23.43% | O: -1.1% H: 1.91% C: -3.82%
MRK | $124.9 -0.38% 1.4M |

Health Technology

| 14.1% | O: 0.11% H: 0.0% C: -1.35%
GSK | $39.44 -0.4% 560K |

Health Technology

| 11.99% | O: -1.02% H: 0.0% C: -0.86%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -5.61% | O: -0.72% H: 0.0% C: 0.0%
conference transdermal

---

Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published: 2022-12-09 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -2.47% | O: -0.89% H: 0.0% C: 0.0%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -50.91% | O: -0.06% H: 2.11% C: -0.06%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -1.54% | O: -0.15% H: 0.0% C: 0.0%
BNTX | $86.085 -0.37% 160K |

Health Technology

| -49.75% | O: -0.05% H: 0.75% C: -0.83%
covid-19 fda designation candidate vaccine influenza fast track designation

---

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.0354 34K |

Communications

| 12.43% | O: -0.76% H: 0.0% C: 0.0%
SNYNF | News | $92.7 1.4K |

Health Technology

| -1.83% | O: 0.5% H: 0.16% C: 0.16%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -49.4% | O: -0.12% H: 3.36% C: 3.19%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -2.83% | O: -1.32% H: 0.0% C: 0.0%
BNTX | $86.085 -0.37% 160K |

Health Technology

| -46.91% | O: 0.37% H: 5.31% C: 5.26%
covid-19 fda children vaccine authorization

---

Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages
Published: 2022-11-18 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| 8.03% | O: 1.56% H: 0.52% C: 0.52%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -47.4% | O: 0.64% H: 0.39% C: -0.84%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| 6.56% | O: 2.2% H: 0.0% C: 0.0%
BNTX | $86.085 -0.37% 160K |

Health Technology

| -48.07% | O: -0.29% H: 0.78% C: 0.37%
report response

---

Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published: 2022-11-16 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| 6.71% | O: -1.22% H: 0.0% C: 0.0%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -47.1% | O: -0.52% H: 1.45% C: 1.11%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| 4.13% | O: -2.28% H: 0.0% C: 0.0%
BNTX | $86.085 -0.37% 160K |

Health Technology

| -47.64% | O: -1.45% H: 2.36% C: 2.31%
covid-19 candidate vaccine study

---

Gainers vs Losers

82%

18%

Top 10 Gainers

AGBA | $0.7995 99.88% 73M |

Finance

BPTH | $6.21 91.67% 58M |

Health Technology

INVO | $1.36 78.95% 3.6M |

Health Technology

TIRX | $0.8258 70.34% 50M |

ISPC | $0.307 44.13% 3.6M |

Professional, Scientific, and T...

SINT | $0.0519 39.14% 350M |

Health Technology

VTNR S | $1.295 32.25% 5.5M |

Industrial Services

ALRN | $5.53 30.12% 250K |

Health Technology

SMSI 4 | $2.53 29.74% 510K |

Technology Services

HOLO | $2.86 27.68% 28M |

---

Your saved searches

---